HANNAH GOLDBERG: Open Payments
NPI 1245771443 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 63 payments from 19 companies in 2025. Trend: 2023 $483 · 2024 $1,249 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $241 |
| Novo Nordisk Inc | 14 | $223 |
| ABBVIE INC. | 8 | $140 |
| AstraZeneca Pharmaceuticals LP | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 2 | $56 |
| Astellas Pharma US Inc | 3 | $47 |
| Amgen Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: Ozempic, NURTEC ODT, JARDIANCE, ELIQUIS, Kerendia, The Cologuard Plus Collection Kit, UBRELVY, Rybelsus.
Industry payments across MD — which companies pay providers there.
